Biomerica, Inc. (BMRA) vs Bolt Biotherapeutics, Inc. (BOLT)
A side-by-side comparison of Biomerica, Inc. and Bolt Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMRA
Biomerica, Inc.
$2.04HealthcareDelayed quote: Oct 6, 2026, 10:44 AM EDT
BOLT
Bolt Biotherapeutics, Inc.
$3.52HealthcareDelayed quote: Oct 6, 2026, 10:17 AM EDT
Total return — BMRA vs BOLT
growth of $100 · dividends reinvested · last 6yBMRA -96.2% (-42.0%/yr)BOLT -99.5% (-58.1%/yr)BMRA compounded faster over this window
Log scale — wide-divergence pair
BMRA BOLT
BMRA vs BOLT: by the numbers
- •BOLT is the larger company ($7M vs $6M market cap).
- •Both run net losses; BMRA's is the smaller (-84.79% vs -611.47% net margin).
Metrics side by side
Valuation
| Metric | BMRA | BOLT |
|---|---|---|
| P/S ratio | 1.42 | 1.44 |
| P/B ratio | 2.40 | 0.54 |
Profitability
| Metric | BMRA | BOLT |
|---|---|---|
| Gross margin | 8.09% | 80.62% |
| Operating margin | -119.54% | -450.07% |
| Net margin | -84.79% | -611.47% |
| ROE | -143.54% | -227.37% |
| ROIC | -117.93% | -90.17% |
Growth (annualized)
| Metric | BMRA | BOLT |
|---|---|---|
| Revenue CAGR (5Y) | -9.17% | N/A |
| Total return CAGR (5Y) | -46.66% | -57.61% |
Frequently asked
- How have BMRA and BOLT total returns compared?
- Over the past 5 years, BMRA delivered -46.66% and BOLT delivered -57.61% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.